According to a revised research report by Future Market Insights (FMI), the Peripheral Vascular Stent Market is on track to register remarkable growth over the next decade. The market, currently valued at USD 4,267.70 million in 2024, is projected to expand at a CAGR of 7.60%, surpassing USD 8,878.00 million by 2034.
This substantial growth is attributed to increasing investments by manufacturers to address the rising prevalence of peripheral artery disease (PAD), along with ongoing innovations in stent design and materials to improve patient outcomes.
Market Growth Drivers
- Rising Peripheral Artery Disease Incidence: A growing global prevalence of PAD is increasing the demand for advanced stents.
- Technological Advancements: Introduction of innovative stent designs and biocompatible materials for enhanced efficacy and durability is propelling market growth.
- Increased Healthcare Investments: Manufacturers are allocating significant resources to develop and launch next-generation peripheral vascular stents.
Key Market Highlights
- Market Valuation in 2024: USD 4,267.70 million
- Forecasted Value in 2034: USD 8,878.00 million
- CAGR (2024-2034): 7.60%
- Growth Contributors: Technological innovations, increasing cases of PAD, and rising global healthcare investments.
Regional Insights
- North America: Expected to dominate due to advanced healthcare infrastructure and a high prevalence of lifestyle diseases contributing to PAD.
- Europe: Significant growth driven by increasing healthcare expenditure and a robust regulatory framework supporting medical device innovation.
- Asia-Pacific: Rapidly emerging as a key market, fueled by rising awareness about PAD, expanding healthcare access, and a growing geriatric population.
- Latin America & Middle East/Africa: Gradual adoption of advanced peripheral vascular stents as healthcare systems evolve.
Innovations Driving Market Trends
- Design Optimization: Development of drug-eluting stents and bioresorbable vascular scaffolds to improve long-term outcomes.
- Material Advancements: Use of novel, biocompatible materials to enhance flexibility and reduce restenosis rates.
Peripheral Vascular Stent Sector Trends and Emerging Opportunities
- Surging consumer preference for drug-eluting stents due to increasing cardiovascular surgeries is expanding the scope of the peripheral vascular stent industry.
- Rising incidences of peripheral arterial disease (PAD) and increasing obesity-inflicted population.
- Technological advancements by market players are enhancing the design and functionality of these stents.
- Manufacturers are contributing to market growth by conducting investigational studies to expand the treatment options for patients suffering from peripheral arterial disease.
- Growing research body on the safety and efficacy of peripheral vascular intervention devices.
Key Insights
Amniotic membranes are utilized for their regenerative properties and are increasingly recognized for their effectiveness in treating a variety of conditions. Their applications span several fields:
- Wound Healing: Used to promote healing in surgical wounds and chronic ulcers.
- Ophthalmology: Employed in procedures to treat ocular surface disorders and enhance corneal healing.
- Tissue Regeneration: Utilized in regenerative medicine to support tissue repair and regeneration.
Growth Drivers
Several factors are contributing to the growth of the amniotic membrane market:
- Increasing Incidence of Chronic Wounds: The rising prevalence of conditions that lead to chronic wounds is driving demand for effective treatment options.
- Advancements in Medical Technology: Innovations in the processing and application of amniotic membranes are enhancing their usability and effectiveness.
- Growing Awareness of Regenerative Medicine: Increased focus on regenerative therapies is promoting the adoption of amniotic membranes in clinical settings.
Competitive Landscape in the Peripheral Vascular Stent Market
Biosensors, Abbott, Boston Scientific, Biotronik, Stryker, Medtronic, Terumo, and B. Braun are identified as powerful players in the peripheral vascular stent market. Their growth is stimulated by the increasing count of cardiovascular surgeries performed alongside minimally invasive techniques.
Medical equipment manufacturers are using market penetrative strategies to gain a large foothold in the industry. The launch of the self-expanding Eluvia drug-eluting stent (DES) system, in the historical period, is a top strategy adopted by market players. This launch served a double benefit as it helped the company extend its PAD portfolio as well as utilize a new drug-polymer combination for the sustained release of the drug paclitaxel.
In the quest to gain a larger foothold in the market, stent makers and medical device manufacturers are investing in research and innovations to elevate their portfolios. ETH Zurich researchers have released a new method to develop malleable microstructure production utilizing indirect 4-D printing.
This latest technology has the potential to develop malleable microstructure production utilizing indirect 4-D printing. Moreover, the government support for certain studied and analyzed product offerings is also encouraging players to expand in this market.
In emerging markets, stent manufacturers are acquiring and merging with other competing players to enhance their position.
Enlisted Below are Some Top Market Players
- Medtronic Plc.
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Abbott Laboratories
- W.L. Gore & Associates Inc.
- Cook Medical Inc.
- Others
A Full Report Overview
Market Segmentation of Peripheral Vascular Stent
By Product Type:
- Self-Expanding Stents
- Balloon-Expanding Stents
- Covered Stents
- Drug-Eluting Stents
Based on Artery Type:
- Carotid Artery
- Fem-Pop Artery
- Iliac Artery
- Infrapop Artery
Peripheral Vascular Stents Market by End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatients
Different Regional Markets are as Follows:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube